The International Journal of Clinical Pharmacology and Therapeutics April 2009 Issue has published the latest peer-reviewed science on TDS-Testosterone. More
Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
FDA ISSUED ORDERS TO SOLVAY AND AUXILIUM TO ADD BLACK BOX LABELS TO THEIR PRODUCTS AS NOTIFICATION TO USERS OF DANGER OF UNINTENDED TRANSFERENCE OF TESTOSTERONE TO FAMILY MEMBERS. TRANSDERMAL TECHNOLOGIES TDS-TESTOSTERONE'S RAPIDLY ABSORBED FORMULA WILL More
At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
APR and the leading pharmaceutical company in Turkey Abdi Ibrahim have entered into an exclusive license agreement for the promotion, distribution and marketing of Ondansetron Rapidfilm® in Turkey; terms of the deal were not disclosed. More
FDA has approved Cambia™, Potassium Diclofenac Powder for Oral Solution for the treatment of acute migraine attacks with or without aura, originally developed by APR Applied Pharma Research SA (APR) using the patented Dynamic Buffering Technology (DBT). More
Pisa -- May, 2006 30th Abiogen Pharma today announced the start of a Phase II clinical trial in Vienna (Austria) in patients affected by GAD with ABIO 08/01, a new anti-anxiety drug. More
All rights reserved. Terms and Conditions | Contact us
